Putative neuroprotective agents in neuropsychiatric disorders
Version 2 2024-05-30, 15:41
Version 1 2014-10-28, 09:58
journal contribution
posted on 2024-05-30, 15:41 authored by Seetal DoddSeetal Dodd, M Maes, G Anderson, Olivia DeanOlivia Dean, Steve MoylanSteve Moylan, Michael BerkMichael BerkPutative neuroprotective agents in neuropsychiatric disorders
History
Journal
Progress in Neuro-Psychopharmacology and Biological PsychiatryVolume
42Pagination
135-145Location
EnglandPublisher DOI
ISSN
0278-5846eISSN
1878-4216Language
EnglishPublication classification
C1 Refereed article in a scholarly journalCopyright notice
2013, ElsevierPublisher
PERGAMON-ELSEVIER SCIENCE LTDPublication URL
Usage metrics
Categories
No categories selectedKeywords
Science & TechnologyLife Sciences & BiomedicineClinical NeurologyNeurosciencesPharmacology & PharmacyPsychiatryNeurosciences & NeurologyAntipsychoticsMelatoninN-acetyl cysteineStatinsBLOOD-BRAIN-BARRIEREXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITISLIPOPOLYSACCHARIDE-INDUCED APOPTOSISHEMATOPOIETIC GROWTH-FACTORSOXIDATIVE STRESS MARKERSA REDUCTASE INHIBITORNEURAL STEM-CELLSOPEN-LABEL TRIALULTRA-HIGH-RISKNF-KAPPA-BNHMRC 628395970111 Expanding Knowledge in the Medical and Health Sciences110319 Psychiatry (incl Psychotherapy)111714 Mental Health920410 Mental HealthInnovation in Mental and Physical Health and Clinical TreatmentSchool of MedicineFaculty of Health
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC